Data Snapshot
UW Medicine Hospitals:
King County: The county reported 83 new positive cases and 0 new death on April 19.
Washington: The state reported 359,810 cases and 5,394 deaths as of April 18.
United States: The CDC reports 31,484,148 cases and 564,292 deaths as of April 19.
Global: WHO reports 141,754,944 confirmed COVID-19 cases and 3,025,835 deaths as of April 20.
Numbers update frequently, please follow links for most up-to-date numbers.
UW Medicine COVID-19 Vaccine Distribution Update
Total Vaccine Doses Administered: 226,453
- Total first dose: 125,198
- Total second dose: 101,255
As of April 18, 2021.
UW Medicine in the News
KING 5: Inslee hopes UW gets part of $1.7 billion in federal COVID-19 variant research funding
Featuring: Helen Chu, Allergy & Infectious Diseases
“On Friday, the Biden administration announced plans to spend $1.7 billion on COVID-19 variant research. Washington Gov. Jay Inslee would like some of that money to go to the University of Washington School of Medicine. ‘I hope that it will allow us to use some federal funding instead of state funding,’ Inslee said. He toured UW Medicine’s South Lake Union lab Friday. ‘A lot of the work we’re doing now is for planning for the future,’ researcher Dr. Helen Chu told Inslee. She presented him with an at-home COVID-19 test and said UW students are taking part in a national study. Students who have been vaccinated will submit swabs daily for the next four months. ‘The goal of the trial is really to understand whether vaccines can prevent carriage of the virus even if you don’t have symptoms,’ said Chu. ‘What we’re trying to answer is, once you get the vaccines, can we bring society back to normal?’”
MLB: Mariners get vaccine info session from UW doctors
Featuring: Vin Gupta, IHME, Santiago Neme, Allergy & Infectious Diseases
“When the Mariners returned from their eight-day road trip on Thursday night, they re-entered Washington state eligible to receive the COVID-19 vaccine. On Saturday, the club continued its active efforts in educating players and staff on the matter with a visit from Dr. Vin Gupta and Dr. Santiago Neme. Gupta is a Seattle-based health policy expert who has worked for the United States Centers for Disease Control, the Institute for Health Metrics and Evaluation, the Harvard Global Health Institute, the World Health Organization and the Pentagon’s Center for Global Health Engagement. He’s also a medical analyst for NBC News, and since the beginning of the pandemic he’s served as the Chief Medical Officer for Amazon and its COVID-19 response. Neme is the vice president and chief medical officer at Northwest Hospital and Medical Center, a branch of University of Washington Medicine. He specializes in infection control and healthcare administration. He’s also been a clinical assistant professor at the UW School of Medicine since 2017.”
Business Insider: US officials may need 2 weeks or more to determine if Johnson & Johnson’s vaccine causes rare blood clots
Featuring: Beth Bell, Global Health
“The CDC’s vaccine advisory panel has already met once to review the rare blood clot cases. At a meeting last Wednesday, the panel recommended continuing the pause on J&J’s vaccine until more data could be gathered. ‘It’s important from the perspective of the public: When we say rare, what does that mean?’ Dr. Beth Bell, a professor of global health at the University of Washington, said during the meeting. ‘I want to be able to feel comfortable with my family members and myself getting this vaccine.” US regulators are now encouraging doctors to report any post-vaccination CVST cases over the last few weeks. Regulators are also working with Johnson & Johnson to find out more about the six reported cases — in particular, whether the women had underlying health problems or were taking any medications that could have predisposed them to clotting.”
COVID-19 Literature Report
COVID-19 Literature Situation Report is a daily (M-F) newsletter put together by the Alliance for Pandemic Preparedness that provides a succinct summary of the latest scientific literature related to the COVID-19 pandemic.
Key Takeaways: COVID-19 Literature Situation Report April 16, 2021
- An estimated 545,600 to 660,200 excess deaths occurred in the US between January 2020 and February 2021, of which 75% to 88% were directly associated with COVID-19. More.
- SARS-COV-2 infection risk was 82% lower among US Marine recruits who were seropositive at baseline compared to seronegative recruits. Over a 6-week period, 19 of 189 (10%) seropositive recruits had at least one positive SARS-CoV-2 PCR test compared to 1,079 of 2,247 (48%) seronegative recruits. More.
- Two separate studies, one of which was conducted among nursing home patients, found that individuals who had a history of SARS-CoV-2 infection showed strong immune responses following a first dose of an mRNA vaccine (Pfizer-BioNTech or Moderna), while vaccine recipients with no history of SARS-CoV-2 infection required a second vaccine dose to reach similar levels of immunologic activity. More and More.
COVID-19 Literature Surveillance Team, is an affiliated group of medical students, PhDs and physicians keeping up with the latest research on SARS-CoV-2 / COVID-19 by finding the newest articles, reading them, grading their level of evidence and bringing you the bottom line.
Read the latest report: April 19 | Daily COVID-19 LST Report.
Tweet of the Week
Hear from @JohnLynchID @UWMedicine about flying in the time of COVID-19 in collaboration with @AlaskaAir and @PacSci @UWDeptMedicine https://t.co/vxOtm36HHV via @YouTube
— UW Medicine Newsroom (@uwmnewsroom) April 19, 2021
